Hill-Rom Holdings Total Assets 2006-2019 | HRC

Hill-Rom Holdings total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Hill-Rom Holdings total assets for the quarter ending March 31, 2019 were $4.368B, a 3.04% decline year-over-year.
  • Hill-Rom Holdings total assets for 2018 were $4.36B, a 3.73% decline from 2017.
  • Hill-Rom Holdings total assets for 2017 were $4.529B, a 6.25% increase from 2016.
  • Hill-Rom Holdings total assets for 2016 were $4.262B, a 4.38% decline from 2015.
Hill-Rom Holdings Annual Total Assets
(Millions of US $)
2018 $4,360
2017 $4,529
2016 $4,262
2015 $4,458
2014 $1,751
2013 $1,587
2012 $1,628
2011 $1,299
2010 $1,246
2009 $1,233
2008 $1,690
2007 $2,117
2006 $1,952
2005 $2,229
Hill-Rom Holdings Quarterly Total Assets
(Millions of US $)
Q2 2019 $4,368
Q1 2018 $4,350
Q4 2018 $4,360
Q3 2018 $4,465
Q2 2018 $4,505
Q1 2017 $4,461
Q4 2017 $4,529
Q3 2017 $4,484
Q2 2017 $4,473
Q1 2016 $4,144
Q4 2016 $4,262
Q3 2016 $4,237
Q2 2016 $4,243
Q1 2015 $4,272
Q4 2015 $4,458
Q3 2015 $1,758
Q2 2015 $1,706
Q1 2014 $1,736
Q4 2014 $1,751
Q3 2014 $1,487
Q2 2014 $1,520
Q1 2013 $1,527
Q4 2013 $1,587
Q3 2013 $1,553
Q2 2013 $1,572
Q1 2012 $1,615
Q4 2012 $1,628
Q3 2012 $1,300
Q2 2012 $1,292
Q1 2011 $1,223
Q4 2011 $1,299
Q3 2011 $1,302
Q2 2011 $1,281
Q1 2010 $1,224
Q4 2010 $1,246
Q3 2010 $1,233
Q2 2010 $1,220
Q1 2009 $1,197
Q4 2009 $1,233
Q3 2009 $1,169
Q2 2009 $1,172
Q1 2008 $1,625
Q4 2008 $1,690
Q3 2008 $1,600
Q2 2008 $1,637
Q1 2007 $2,165
Q4 2007 $2,117
Q3 2007 $2,068
Q2 2007 $2,035
Q1 2006 $2,003
Q4 2006 $1,952
Q3 2006 $2,190
Q2 2006 $2,128
Q1 2005 $2,264
Q4 2005 $2,229
Q3 2005 $1,992
Q2 2005 $2,055
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $6.993B $2.470B
HILL-ROM HOLDINGS, Inc. traces its roots back to 1929 when William A. Hillenbrand formed the company as a division of Hillenbrand Industries. At that time, the company was focused on developing innovative beds and furnishings for hospital patient rooms. Now, after nearly eighty years, Hill-Rom leads the way as an innovator in the medical technology field developing solutions that enhance outcomes for patients and their caregivers.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $147.856B 28.70
Medtronic (MDT) Ireland $133.874B 19.12
Stryker (SYK) United States $76.669B 27.36
Boston Scientific (BSX) United States $59.033B 28.30
Baxter (BAX) United States $41.839B 26.37
EssilorLuxottica Societe Anonyme (ESLOY) France $29.060B 0.00
Coloplast (CLPBY) Denmark $25.618B 40.90
Zimmer Biomet Holdings (ZBH) United States $24.965B 16.04
Lonza Group Ag (LZAGY) Switzerland $24.947B 0.00
Terumo (TRUMY) Japan $23.393B 26.90
Smith & Nephew SNATS (SNN) United Kingdom $19.274B 0.00
ResMed (RMD) United States $17.745B 33.90
Canopy Growth (CGC) Canada $12.161B 0.00
Sunny Optical Technology (SNPTF) China $12.027B 0.00
Bio-Rad Laboratories (BIO) United States $9.308B 49.34
William Demant Holdings (WILYY) Denmark $7.651B 0.00
Insulet (PODD) United States $7.203B 524.78
Aurora Cannabis (ACB) Canada $7.109B 70.10
Perrigo (PRGO) Ireland $7.004B 11.84
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
Haemonetics (HAE) United States $6.325B 51.63
ICU Medical (ICUI) United States $5.135B 30.64
GW Pharmaceuticals (GWPH) United Kingdom $5.057B 0.00
Neogen (NEOG) United States $3.349B 54.45
NuVasive (NUVA) United States $2.982B 24.36
Hutchison China MediTech (HCM) China $2.925B 0.00
Agios Pharmaceuticals (AGIO) United States $2.711B 0.00
National Vision Holdings (EYE) United States $2.420B 51.57
Quidel (QDEL) United States $2.309B 23.96
Cardiovascular Systems (CSII) United States $1.598B 917.80
Aphria (APHA) $1.579B 0.00
Phibro Animal Health (PAHC) United States $1.229B 18.41
AtriCure (ATRC) United States $1.218B 0.00
VAREX IMAGING (VREX) United States $1.187B 25.19
Lantheus Holdings (LNTH) United States $1.089B 28.93
NanoString Technologies (NSTG) United States $1.056B 0.00
PetIQ (PETQ) United States $0.994B 24.14
MacroGenics (MGNX) United States $0.777B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.765B 21.47
Cerus (CERS) United States $0.758B 0.00
Quanterix (QTRX) United States $0.753B 0.00
Omeros (OMER) United States $0.750B 0.00
TG Therapeutics (TGTX) United States $0.698B 0.00
LeMaitre Vascular (LMAT) United States $0.572B 27.71
Surmodics (SRDX) United States $0.543B 78.88
OraSure Technologies (OSUR) United States $0.531B 24.43
Meridian Bioscience (VIVO) United States $0.476B 14.56
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.404B 0.00
Vapotherm (VAPO) United States $0.345B 0.00
Utah Medical Products (UTMD) United States $0.320B 22.13
BioLife Solutions (BLFS) United States $0.304B 95.24
Zynex (ZYXI) United States $0.250B 25.67
Bovie Medical (APYX) United States $0.236B 0.00
Cytosorbents (CTSO) United States $0.227B 0.00
Owens & Minor (OMI) United States $0.198B 4.20
Chimerix (CMRX) United States $0.188B 0.00
United Health Products (UEEC) United States $0.175B 0.00
Rockwell Medical (RMTI) United States $0.170B 0.00
Female Health (VERU) United States $0.146B 0.00
Fonar (FONR) United States $0.139B 7.33
Chembio Diagnostics (CEMI) United States $0.098B 0.00
United-Guardian (UG) United States $0.094B 20.65
InfuSystems Holdings (INFU) United States $0.090B 0.00
Surface Oncology (SURF) United States $0.075B 0.00
Trinity Biotech (TRIB) Ireland $0.060B 20.75
Oramed Pharmaceuticals (ORMP) United States $0.058B 0.00
MRI INTERVENTNS (MRIC) United States $0.052B 0.00